Gå till sökfältet
Gå till sidans huvudinnehåll
Gå till tillgänglighetsredogörelsen
Forskning.fi
Menu
Suomeksi
På svenska
In English
Ingångssida
Sökning
Vetenskaps- och innovationspolitik
Vetenskaps- och forskningsnyheter
På svenska
- 214 results
Publikationer
214
Utlysningar
0
Beviljade finansiering
8
Personer
0
Data
1
Infrastrukturer
0
Organisationer
0
Projekt
4
Publikationer -
214
sökresultat
Gå till sökresultaten
Visa som bild
Begränsa sökning
Resultaten visas 1 - 10 / 214
10
50
100
resultat / per sida
Vilka
publikations
uppgifter finns i tjänsten?
Icon
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon
A
2A
R
antagonist
treatment for multiple sclerosis: Current progress and future prospects
Referentgranskad
DOI
10.1016/bs.irn.2023.05.012
Chenxing Qi; Yijia Feng; Yiwei Jiang; Wangchao Chen; Serhii Vakal; Jiang Fan Chen; Wu Zheng
Adenosine A Receptor
Antagonist
s
2023
Publicationer information ikon
Continued non-vitamin K
antagonist
oral anticoagulants versus vitamin K
antagonist
s during transcatheter aortic valve implantation
Referentgranskad
Öppen tillgång
DOI
10.4244/EIJ-D-22-00521
Mangner, Norman; Brinkert, Miriam; Keller, Lukas S.; Moriyama, Noriaki; Hagemeyer, Daniel; Haussig, ...
Eurointervention
2023
Publicationer information ikon
Peripherally acting alpha-adrenoceptor
antagonist
MK-467 with intramuscular medetomidine and butorphanol in dogs:A prospective, randomised, clinical trial
Referentgranskad
Öppen tillgång
DOI
10.1016/j.tvjl.2018.08.007
Kallio-Kujala, I. J.; Turunen, H. A.; Raekallio, M. R.; Honkavaara, J. M.; Salla, K. M.; Casoni, D.;...
The Veterinary Journal
2018
Publicationer information ikon
GnRH
antagonist
treatment of malignant adrenocortical tumors
Referentgranskad
Öppen tillgång
DOI
10.1530/ERC-17-0399
Doroszko M, Chrusciel M, Stelmaszewska J, Slezak T, Anisimowicz S, Plöckinger U, Quinkler M, Bonomi ...
Endocrine-Related Cancer
2019
Publicationer information ikon
GnRH
antagonist
treatment of malignant adrenocortical tumors
Referentgranskad
Doroszko M; Chrusciel M; Stelmaszewska J; Slezak T; et al; Toppari J
Endocrine-Related Cancer
2019
Publicationer information ikon
The selective kappa-opioid receptor
antagonist
JDTic attenuates the alcohol deprivation effect in rats
Referentgranskad
Öppen tillgång
DOI
10.1016/j.euroneuro.2019.10.003
Uhari-Väänänen, Johanna; Eteläinen, Tony; Bäckström, Pia; Oinio, Ville; Carroll, F. Ivy; Raasmaja, A...
European neuropsychopharmacology
2019
Publicationer information ikon
The mineralocorticoid receptor
antagonist
spironolactone enhances morphine antinociception
Referentgranskad
DOI
10.1002/j.1532-2149.2013.00371.x
Lilius, T. O.; Jokinen, V.; Neuvonen, M. S.; Vaananen, A. J.; Niemi, Mikko; Rauhala, P. V.; Kalso, E...
European journal of pain
2014
Publicationer information ikon
Cardiovascular effects of ghrelin
antagonist
in conscious rats
Referentgranskad
DOI
10.1016/j.regpep.2009.04.016
Vlasova MA, Järvinen K, Herzig KH
Regul Pept
2009
Publicationer information ikon
Concentrations of medetomidine enantiomers and vatinoxan, an α
2
-adrenoceptor
antagonist
, in plasma and central nervous tissue after intravenous coadministration in dogs
Referentgranskad
Öppen tillgång
DOI
10.1016/j.vaa.2019.07.004
Honkavaara, Juhana M.; Raekallio, Marja R.; Syrja, Pernilla M.; Pypendop, Bruno H.; Knych, Heather K...
Veterinary Anaesthesia and Analgesia
2020
Publicationer information ikon
Synthesis of 7β-hydroxy-8-ketone opioid derivatives with
antagonist
activity at mu- and delta-opioid receptors
Referentgranskad
Öppen tillgång
DOI
10.1016/j.ejmech.2018.02.074
Ahonen, Tiina J.; Rinne, Maiju; Grutschreiber, Peter; Mätlik, Kert; Airavaara, Mikko; Schaarschmidt,...
European Journal of Medicinal Chemistry
2018
A
2A
R
antagonist
treatment for multiple sclerosis: Current progress and future prospects
Referentgranskad
DOI
10.1016/bs.irn.2023.05.012
2023
Continued non-vitamin K
antagonist
oral anticoagulants versus vitamin K
antagonist
s during transcatheter aortic valve implantation
Referentgranskad
Öppen tillgång
DOI
10.4244/EIJ-D-22-00521
2023
Peripherally acting alpha-adrenoceptor
antagonist
MK-467 with intramuscular medetomidine and butorphanol in dogs:A prospective, randomised, clinical trial
Referentgranskad
Öppen tillgång
DOI
10.1016/j.tvjl.2018.08.007
2018
GnRH
antagonist
treatment of malignant adrenocortical tumors
Referentgranskad
Öppen tillgång
DOI
10.1530/ERC-17-0399
2019
GnRH
antagonist
treatment of malignant adrenocortical tumors
Referentgranskad
2019
The selective kappa-opioid receptor
antagonist
JDTic attenuates the alcohol deprivation effect in rats
Referentgranskad
Öppen tillgång
DOI
10.1016/j.euroneuro.2019.10.003
2019
The mineralocorticoid receptor
antagonist
spironolactone enhances morphine antinociception
Referentgranskad
DOI
10.1002/j.1532-2149.2013.00371.x
2014
Cardiovascular effects of ghrelin
antagonist
in conscious rats
Referentgranskad
DOI
10.1016/j.regpep.2009.04.016
2009
Concentrations of medetomidine enantiomers and vatinoxan, an α
2
-adrenoceptor
antagonist
, in plasma and central nervous tissue after intravenous coadministration in dogs
Referentgranskad
Öppen tillgång
DOI
10.1016/j.vaa.2019.07.004
2020
Synthesis of 7β-hydroxy-8-ketone opioid derivatives with
antagonist
activity at mu- and delta-opioid receptors
Referentgranskad
Öppen tillgång
DOI
10.1016/j.ejmech.2018.02.074
2018
Föregående
1
2
3
4
5
Nästa
Resultaten visas 1 - 10 / 214
Sida 1
Sort
